| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702748 | Urologic Oncology: Seminars and Original Investigations | 2017 | 8 Pages |
Abstract
These results indicate that KIFC1 plays an important role in PCa progression. Immunohistochemical analysis of KIFC1 would facilitate identification of patients with poor prognoses after radical prostatectomy, as well as patients with poor therapeutic outcomes after docetaxel-based chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yohei M.D., Naohide M.D., Ph.D., Yoshinori M.D., Akira M.D., Naoya M.D., Ph.D., Kazuhiro M.D., Ph.D., Jun M.D., Ph.D., Akio M.D., Ph.D., Wataru M.D., Ph.D.,